Cargando…
Post-COVID syndrome screening through breath analysis using electronic nose technology
There is an urgent need to have reliable technologies to diagnose post-coronavirus disease syndrome (PCS), as the number of people affected by COVID-19 and related complications is increasing worldwide. Considering the amount of risks associated with the two chronic lung diseases, asthma and chronic...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930465/ https://www.ncbi.nlm.nih.gov/pubmed/35303135 http://dx.doi.org/10.1007/s00216-022-03990-z |
_version_ | 1784671067491532800 |
---|---|
author | V. R., Nidheesh Mohapatra, Aswini Kumar V. K., Unnikrishnan Lukose, Jijo Kartha, Vasudevan Baskaran Chidangil, Santhosh |
author_facet | V. R., Nidheesh Mohapatra, Aswini Kumar V. K., Unnikrishnan Lukose, Jijo Kartha, Vasudevan Baskaran Chidangil, Santhosh |
author_sort | V. R., Nidheesh |
collection | PubMed |
description | There is an urgent need to have reliable technologies to diagnose post-coronavirus disease syndrome (PCS), as the number of people affected by COVID-19 and related complications is increasing worldwide. Considering the amount of risks associated with the two chronic lung diseases, asthma and chronic obstructive pulmonary disease (COPD), there is an immediate requirement for a screening method for PCS, which also produce symptoms similar to these conditions, especially since very often, many COVID-19 cases remain undetected because a good share of such patients is asymptomatic. Breath analysis techniques are getting attention since they are highly non-invasive methods for disease diagnosis, can be implemented easily for point-of-care applications even in primary health care centres. Electronic (E-) nose technology is coming up with better reliability, ease of operation, and affordability to all, and it can generate signatures of volatile organic compounds (VOCs) in exhaled breath as markers of diseases. The present report is an outcome of a pilot study using an E-nose device on breath samples of cohorts of PCS, asthma, and normal (control) subjects. Match/no-match and k-NN analysis tests have been carried out to confirm the diagnosis of PCS. The prediction model has given 100% sensitivity and specificity. Receiver operating characteristics (ROC) has been plotted for the prediction model, and the area under the curve (AUC) is obtained as 1. The E-nose technique is found to be working well for PCS diagnosis. Our study suggests that the breath analysis using E-nose can be used as a point-of-care diagnosis of PCS. Trial registration Breath samples were collected from the Kasturba Hospital, Manipal. Ethical clearance was obtained from the Institutional Ethics Committee, Kasturba Medical College, Manipal (IEC 60/2021, 13/01/2021) and Indian Council of Medical Research (ICMR) (CTRI/2021/02/031357, 06/02/2021) Government of India; trials were prospectively registered. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00216-022-03990-z. |
format | Online Article Text |
id | pubmed-8930465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-89304652022-03-18 Post-COVID syndrome screening through breath analysis using electronic nose technology V. R., Nidheesh Mohapatra, Aswini Kumar V. K., Unnikrishnan Lukose, Jijo Kartha, Vasudevan Baskaran Chidangil, Santhosh Anal Bioanal Chem Research Paper There is an urgent need to have reliable technologies to diagnose post-coronavirus disease syndrome (PCS), as the number of people affected by COVID-19 and related complications is increasing worldwide. Considering the amount of risks associated with the two chronic lung diseases, asthma and chronic obstructive pulmonary disease (COPD), there is an immediate requirement for a screening method for PCS, which also produce symptoms similar to these conditions, especially since very often, many COVID-19 cases remain undetected because a good share of such patients is asymptomatic. Breath analysis techniques are getting attention since they are highly non-invasive methods for disease diagnosis, can be implemented easily for point-of-care applications even in primary health care centres. Electronic (E-) nose technology is coming up with better reliability, ease of operation, and affordability to all, and it can generate signatures of volatile organic compounds (VOCs) in exhaled breath as markers of diseases. The present report is an outcome of a pilot study using an E-nose device on breath samples of cohorts of PCS, asthma, and normal (control) subjects. Match/no-match and k-NN analysis tests have been carried out to confirm the diagnosis of PCS. The prediction model has given 100% sensitivity and specificity. Receiver operating characteristics (ROC) has been plotted for the prediction model, and the area under the curve (AUC) is obtained as 1. The E-nose technique is found to be working well for PCS diagnosis. Our study suggests that the breath analysis using E-nose can be used as a point-of-care diagnosis of PCS. Trial registration Breath samples were collected from the Kasturba Hospital, Manipal. Ethical clearance was obtained from the Institutional Ethics Committee, Kasturba Medical College, Manipal (IEC 60/2021, 13/01/2021) and Indian Council of Medical Research (ICMR) (CTRI/2021/02/031357, 06/02/2021) Government of India; trials were prospectively registered. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00216-022-03990-z. Springer Berlin Heidelberg 2022-03-18 2022 /pmc/articles/PMC8930465/ /pubmed/35303135 http://dx.doi.org/10.1007/s00216-022-03990-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Paper V. R., Nidheesh Mohapatra, Aswini Kumar V. K., Unnikrishnan Lukose, Jijo Kartha, Vasudevan Baskaran Chidangil, Santhosh Post-COVID syndrome screening through breath analysis using electronic nose technology |
title | Post-COVID syndrome screening through breath analysis using electronic nose technology |
title_full | Post-COVID syndrome screening through breath analysis using electronic nose technology |
title_fullStr | Post-COVID syndrome screening through breath analysis using electronic nose technology |
title_full_unstemmed | Post-COVID syndrome screening through breath analysis using electronic nose technology |
title_short | Post-COVID syndrome screening through breath analysis using electronic nose technology |
title_sort | post-covid syndrome screening through breath analysis using electronic nose technology |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930465/ https://www.ncbi.nlm.nih.gov/pubmed/35303135 http://dx.doi.org/10.1007/s00216-022-03990-z |
work_keys_str_mv | AT vrnidheesh postcovidsyndromescreeningthroughbreathanalysisusingelectronicnosetechnology AT mohapatraaswinikumar postcovidsyndromescreeningthroughbreathanalysisusingelectronicnosetechnology AT vkunnikrishnan postcovidsyndromescreeningthroughbreathanalysisusingelectronicnosetechnology AT lukosejijo postcovidsyndromescreeningthroughbreathanalysisusingelectronicnosetechnology AT karthavasudevanbaskaran postcovidsyndromescreeningthroughbreathanalysisusingelectronicnosetechnology AT chidangilsanthosh postcovidsyndromescreeningthroughbreathanalysisusingelectronicnosetechnology |